首次!顶刊发表中国创新药试验;新冠中和抗体对变异株无效被撤回 CN-Healthcare, 31 Jan 2023 今日行业热点 ①The New England Journal of Medicine:Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia…